Lv3
380 积分 2023-02-20 加入
The effects of subconjunctival bevacizumab, ranibizumab, and aflibercept on corneal neovascularization
1天前
待确认
Corneal Neovascularization: Pathogenesis, Current Insights and Future Strategies
1天前
待确认
The evolving landscape of drug targets
6天前
已完结
Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer
11天前
已完结
Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial
13天前
已完结
Switching on elusive organometallic mechanisms with photoredox catalysis
1个月前
已完结
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
1个月前
已完结
Designing small-molecule binding proteins
1个月前
已完结
Discovery of Novel CBP/p300 and BRD4 Dual-Target PROTACs with Potent Antitumor Activity in Prostate Cancer
2个月前
已完结
Discovery of ZX079 as a Dual PROTAC Degrader Targeting BRD4/CBP in Acute Myeloid Leukemia
2个月前
已完结
皖公网安备34019202002308
